Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Piotrowski

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 16, 2009
The discovery of novel calcium sensing receptor negative allosteric modulatorsGayatri Balan, Jonathan Bauman, Samit Bhattacharya, et al.
Journal of Medicinal Chemistry|April 4, 2015
Short Hydrophobic Peptides with Cyclic Constraints Are Potent Glucagon-like Peptide-1 Receptor (GLP-1R) AgonistsHuy N Hoang, Kun Song, Timothy A Hill, et al.
Journal of Medicinal Chemistry|June 8, 2018
Small Molecule Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors: Hit to Lead Optimization of Systemic AgentsAllyn T Londregan, Liuqing Wei, Jun Xiao, et al.
Journal of Medicinal Chemistry|April 18, 2014
Identification of (R)-6-(1-(4-cyano-3-methylphenyl)-5-cyclopentyl-4,5-dihydro-1H-pyrazol-3-yl)-2-methoxynicotinic acid, a highly potent and selective nonsteroidal mineralocorticoid receptor antagonistAgustin Casimiro-Garcia, David W Piotrowski, Catherine Ambler, et al.
Bioorganic & Medicinal Chemistry Letters|August 9, 2023
Positive allosteric modulators of the α7 nicotinic acetylcholine receptor: SAR investigation around PNU-120596Brad A Acker, Valentina O Badescu, Mitchell B Berkenpas, et al.
Journal of Medicinal Chemistry|April 10, 2018
Discovery of a Novel Small-Molecule Modulator of C-X-C Chemokine Receptor Type 7 as a Treatment for Cardiac FibrosisElnaz Menhaji-Klotz, Kevin D Hesp, Allyn T Londregan, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2008
Discovery of N-[(3R,5R)-1-azabicyclo[3.2.1]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide as an agonist of the alpha7 nicotinic acetylcholine receptor: in vitro and in vivo activityBrad A Acker, E Jon Jacobsen, Bruce N Rogers, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Identification of Tetrahydropyrido[4,3-d]pyrimidine Amides as a New Class of Orally Bioavailable TGR5 AgonistsDavid W Piotrowski, Kentaro Futatsugi, Joseph S Warmus, et al.
Journal of Medicinal Chemistry|June 1, 2022
A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 ReceptorDavid A Griffith, David J Edmonds, Jean-Philippe Fortin, et al.
Angewandte Chemie (International Ed. in English)|October 27, 2017
Liver-Targeted Small-Molecule Inhibitors of Proprotein Convertase Subtilisin/Kexin Type 9 SynthesisKim F McClure, David W Piotrowski, Donna Petersen, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry Letters|May 16, 2009
The discovery of novel calcium sensing receptor negative allosteric modulatorsGayatri Balan, Jonathan Bauman, Samit Bhattacharya, et al.
Journal of Medicinal Chemistry|April 4, 2015
Short Hydrophobic Peptides with Cyclic Constraints Are Potent Glucagon-like Peptide-1 Receptor (GLP-1R) AgonistsHuy N Hoang, Kun Song, Timothy A Hill, et al.
Journal of Medicinal Chemistry|June 8, 2018
Small Molecule Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors: Hit to Lead Optimization of Systemic AgentsAllyn T Londregan, Liuqing Wei, Jun Xiao, et al.
Journal of Medicinal Chemistry|April 18, 2014
Identification of (R)-6-(1-(4-cyano-3-methylphenyl)-5-cyclopentyl-4,5-dihydro-1H-pyrazol-3-yl)-2-methoxynicotinic acid, a highly potent and selective nonsteroidal mineralocorticoid receptor antagonistAgustin Casimiro-Garcia, David W Piotrowski, Catherine Ambler, et al.
Bioorganic & Medicinal Chemistry Letters|August 9, 2023
Positive allosteric modulators of the α7 nicotinic acetylcholine receptor: SAR investigation around PNU-120596Brad A Acker, Valentina O Badescu, Mitchell B Berkenpas, et al.
Journal of Medicinal Chemistry|April 10, 2018
Discovery of a Novel Small-Molecule Modulator of C-X-C Chemokine Receptor Type 7 as a Treatment for Cardiac FibrosisElnaz Menhaji-Klotz, Kevin D Hesp, Allyn T Londregan, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2008
Discovery of N-[(3R,5R)-1-azabicyclo[3.2.1]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide as an agonist of the alpha7 nicotinic acetylcholine receptor: in vitro and in vivo activityBrad A Acker, E Jon Jacobsen, Bruce N Rogers, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Identification of Tetrahydropyrido[4,3-d]pyrimidine Amides as a New Class of Orally Bioavailable TGR5 AgonistsDavid W Piotrowski, Kentaro Futatsugi, Joseph S Warmus, et al.
Journal of Medicinal Chemistry|June 1, 2022
A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 ReceptorDavid A Griffith, David J Edmonds, Jean-Philippe Fortin, et al.
Angewandte Chemie (International Ed. in English)|October 27, 2017
Liver-Targeted Small-Molecule Inhibitors of Proprotein Convertase Subtilisin/Kexin Type 9 SynthesisKim F McClure, David W Piotrowski, Donna Petersen, et al.
Pageof 5